Industry: Biopharma / Rare Disease
Engagement Type: Patient Advocacy Insight & Launch Strategy
Background
A biopharmaceutical company preparing to launch a new treatment for a rare metabolic disorder sought a comprehensive understanding of the online community—spanning patients, caregivers, clinicians, and advocacy groups. The goal was to ensure that its communications and outreach efforts were aligned with the lived experiences and needs of those affected by the condition.
Problem
Discussions around the disorder were fragmented across platforms such as social media, forums, and advocacy networks. Without a consolidated view of patient sentiment, treatment expectations, and community priorities, the launch risked being misaligned with stakeholder concerns and missing opportunities for meaningful engagement.
Solution
Ringer Sciences conducted a year-long conversation analysis of over 9,000 social and media mentions. Insights were segmented by stakeholder type and content theme, including dietary management, treatment experiences, clinical trials, and advocacy efforts. Influential advocates and high-impact social media voices were also identified for potential partnership opportunities and content co-creation.
Results
- Engaged 10+ trusted patient and caregiver influencers, boosting authenticity and reach through online partnerships.
- Developed audience-specific campaign content for education and awareness across platforms.
- Aligned all launch messaging with verified community pain points and unmet needs, ensuring relevance.
- Built a scalable framework for long-term advocacy engagement and co-created content pipelines.
Outcome
Enabled a highly targeted and trust-driven launch strategy that aligned directly with community sentiment, increasing awareness and engagement ahead of market entry.
